共 140 条
- [1] Kane M(1995)Global programme for control of hepatitis B infection Vaccine 13 S47-9
- [2] Doong SL(1991)Inhibition of the replication of hepatitis B virus in vitro by 2,3-dideoxy-3-thiacytidine and related analogues Proc Natl Acad Sci U S A 88 8495-9
- [3] Tsai CH(1995)A preliminary trial of lamivudine for chronic hepatitis B infection N Engl J Med 333 1657-61
- [4] Schinazi RF(1997)Lamivudine therapy for chronic hepatitis B: a 6-month randomized dose: ranging study Gastroenterology 113 1258-63
- [5] Liotta DC(1998)Lamivudine therapy for chronic hepatitis B: a 12-month double-blind, placebo-controlled multicenter study N Engl J Med 339 61-8
- [6] Cheng YC(2001)Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: a preliminary study Am J Gastroenterol 96 557-62
- [7] Dienstag JL(1999)Histological changes in liver biopsies after 1 year of lamivudine treatment in patients with chronic hepatitis B infection J Hepatol 30 743-8
- [8] Perrillo RP(2003)Histological improvements after a 3-year lamivudine therapy in patients with chronic hepatitis B in whom YMDD mutants did not or did develop Intervirology 46 164-70
- [9] Schiff ER(2004)Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis J Gastroenterol 39 1078-84
- [10] Bartolomew M(2005)Favorable Efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: an 8-year follow-up study J Med Virol 75 491-8